# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000906709-22-000005
Filing Date
2022-03-01
Accepted
2022-02-28 18:52:26
Documents
92
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | nktr-20211231.htm iXBRL | 10-K | 2321977
2 | EX-10.40 | nktr20211231-exx1040.htm | EX-10.40 | 63818
3 | EX-21.1 | nktr20211231-exx211.htm | EX-21.1 | 2661
4 | EX-23.1 | nktr20211231-exx231.htm | EX-23.1 | 5742
5 | EX-31.1 | nktr-20211231xexx311.htm | EX-31.1 | 8096
6 | EX-31.2 | nktr-20211231xexx312.htm | EX-31.2 | 8139
7 | EX-32.1 | nktr-20211231xexx321.htm | EX-32.1 | 6342
13 | GRAPHIC | nktr-20211231_g1.jpg | GRAPHIC | 70640
| Complete submission text file | 0000906709-22-000005.txt |  | 10290347

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nktr-20211231.xsd | EX-101.SCH | 80484
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nktr-20211231_cal.xml | EX-101.CAL | 98795
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nktr-20211231_def.xml | EX-101.DEF | 353249
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nktr-20211231_lab.xml | EX-101.LAB | 863479
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nktr-20211231_pre.xml | EX-101.PRE | 534701
86 | EXTRACTED XBRL INSTANCE DOCUMENT | nktr-20211231_htm.xml | XML | 1612285

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 22692729
SIC: 2834 Pharmaceutical Preparations